A skilled nursing facility's medical director wants to implement a new policy to restrict the automatic therapeutic interchange of proton pump inhibitors (PPIs). What is the most appropriate professional role for the consultant pharmacist in this situation?
-
A
Defer the decision entirely to the facility administrator and the director of nursing.
-
B
Research and present evidence-based guidelines and cost-benefit analyses to the P&T committee to help formulate the policy.
-
C
Implement the policy immediately as directed by the medical director without further review.
-
D
Inform the dispensing pharmacy that all therapeutic interchanges are now prohibited.